Settlement With Eli Lilly Over Insulin Costs Falls Apart In National Class Action
NEWARK, N.J. — A proposed settlement between Eli Lilly & Co. and class members in which the drugmaker would pay $13.5 million for an insulin XE "insulin" price claims fund and...To view the full article, register now.
Already a subscriber? Click here to view full article